EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia

Nina Treder iD, Albert Martínez-Pinteño iD, Natalia Rodríguez, Néstor Arbelo, Santiago Madero iD, Marta Gómez, Clemente García-Rizo iD, Sergi Mas, Patricia Gassó, Eduard Parellada, Constanza Morén iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nina Treder und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Psychology and Neuroscience, Maastricht University, 6211 LK Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Clozapine, Ketamine, Schizophrenia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Spanish Ministry of Economy, Industry, and Competitiveness, Fondo de Investigación Sanitaria (FIS)—The European Regional Development Fund (FEDER—una manera de hacer Europa).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia (SZ) is a heterogeneous mental disorder, affecting ~1% of the worldwide population. One of the main pathophysiological theories of SZ is the imbalance of excitatory glutamatergic pyramidal neurons and inhibitory GABAergic interneurons, involving N-methyl-D-aspartate receptors (NMDAr). This may lead to local glutamate storms coupled with excessive dendritic pruning and subsequent cellular stress, including nitrosative stress, during a critical period of neurodevelopment, such as adolescence. Nitrosative stress is mediated by nitric oxide (NO), which is released by NO synthases (NOS) and has emerged as a key signaling molecule implicated in SZ. Regarding glutamatergic models of SZ, the administration of NMDAr antagonists has been found to increase NOS levels in the prefrontal cortex (PFC) and ventral hippocampus (HPC). We hypothesized that suboptimal NOS function in adolescence could be a target for early treatments, including clozapine (CLZ) and the novel metabotropic glutamate receptor modulator JNJ-46356479 (JNJ). We analyzed the protein levels of NOS isoforms in adult PFC and HPC of a postnatal ketamine induced murine model of SZ receiving CLZ or JNJ during adolescence by western blot. Endothelial NOS and neuronal NOS increased under ketamine administration in PFC and decreased in CLZ or JNJ treatments. The same trends were found in the HPC in neuronal NOS. In contrast, inducible NOS was increased under JNJ treatment with respect to ketamine induction in the HPC, and the same trends were found in the PFC. Taken together, our findings suggest a misbalance of the NOS system following NMDAr antagonist administration, which was then modulated under early CLZ and JNJ treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineKetamineSchizophreniaHumansAdultMiceAnimalsGlutamic AcidNitrosative StressPrefrontal CortexReceptors, N-Methyl-D-Aspartate

Stichwörter der Autor:innen

clozapineglutamate metabotropic modulatorketaminenitrosative stressschizophrenia

Substanzen

ClozapineKetamineGlutamic AcidReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Faculty of Psychology and Neuroscience, Maastricht University, 6211 LK Maastricht, The Netherlands.
  • Pharmacology Unit, Department of Basic and Clinical Practice, University of Barcelona, 08036 Barcelona, Spain.
  • Clinical and Experimental Neuroscience Area, The August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
  • Barcelona Clínic Schizophrenia Unit, Institute of Neuroscience, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
  • G04 Group, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.
  • Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (SERGAS), 36312 Vigo, Spain.

ORCID-Profile: Nina Treder, Albert Martínez-Pinteño, Santiago Madero, Clemente García-Rizo, Constanza Morén

Förderung

  • Instituto de Salud Carlos III
  • Spanish Ministry of Economy, Industry, and Competitiveness
  • Fondo de Investigación Sanitaria (FIS)—The European Regional Development Fund (FEDER—una manera de hacer Europa)
  • Unión Europea, the “Pons Balmes”
  • Government of Catalonia, Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement

Zitieren

APA

Treder, N., Martínez-Pinteño, A., Rodríguez, N., Arbelo, N., Madero, S., Gómez, M., García-Rizo, C., Mas, S., Gassó, P., Parellada, E., & Morén, C. (2023). The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021022

Vancouver

Treder N, Martínez-Pinteño A, Rodríguez N, Arbelo N, Madero S, Gómez M, et al. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021022

BibTeX
@article{Treder2023,
  author = {Treder, Nina and Martínez-Pinteño, Albert and Rodríguez, Natalia and Arbelo, Néstor and Madero, Santiago and Gómez, Marta and García-Rizo, Clemente and Mas, Sergi and Gassó, Patricia and Parellada, Eduard and Morén, Constanza},
  title = {The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021022}
}
Kostenlos starten →